Filing Details
- Accession Number:
- 0000784199-17-000027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-24 09:10:17
- Reporting Period:
- 2017-02-22
- Filing Date:
- 2017-02-24
- Accepted Time:
- 2017-02-24 09:10:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Cryolife Inc | CRY | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409753 | B Scott Capps | Cryolife, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144 | Vp, Clinical Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-22 | 16,667 | $7.01 | 128,477 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-22 | 11,083 | $16.40 | 117,394 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2017-02-22 | 16,667 | $16.40 | 16,667 | $7.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-02-22 | 2017-02-22 | No | 4 | M | Direct |
Footnotes
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011
- Reflects weighted average price. Range was $16.35 to $16.45 The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
